SCHEMBL19606563

SCHEMBL19606563

CCCCCNC(=O)CNC

nearest known ligand 0.61

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CASP2 P42575 1/20 0.61
NAAA Q02083 1/20 0.57
EPHX1 P07099 6/20 0.56
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
FAAH O00519 2/20 0.52
LPAR1 Q92633 1/20 0.49
EPHX2 P34913 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22340820 0.98 CASP2 (0.64) CASP2NAAAEPHX1MEN1KMT2A
SCHEMBL25950981 0.98 CASP2 (0.64) CASP2NAAAEPHX1MEN1KMT2A
SCHEMBL21613628 0.98 CASP2 (0.64) CASP2NAAAEPHX1MEN1KMT2A
SCHEMBL11014644 0.98 CASP2 (0.64) CASP2NAAAEPHX1MEN1KMT2A
SCHEMBL8209484 0.93 CASP2 (0.52) CASP2NAAAEPHX1MEN1KMT2A
SCHEMBL25449079 0.89 EPHX2 (0.65) LPAR1EPHX2
SCHEMBL11832089 0.89 EPHX2 (0.65) LPAR1EPHX2
SCHEMBL25091844 0.88 CASP2 (0.68) CASP2NAAAMEN1KMT2AFAAH
SCHEMBL25477974 0.87 S1PR2 (0.53) CASP2NAAAEPHX1FAAH
SCHEMBL25140466 0.86 MEN1 (0.52) CASP2NAAAEPHX1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4227315-A1 COMPOUND TARGETING PROSTATE SPECIFIC MEMBRANE ANTIGEN, AND PREPARATION METHOD THEREFOR AND USE THEREOF Yantai Lannacheng Biotechnology Co., Ltd. (CN) 2023-08-16 EP disclosed
US-20230146870-A1 METHOD TO QUANTIFY AFFINITY AND SELECTIVITY OF SMALL MOLECULES FOR PROTEINS IN LIVING CELLS OHIO STATE INNOVATION FOUNDATION 2023-05-11 US disclosed
WO-2017197051-A1 AMINE-LINKED C3-GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN DEGRADATION C4 THERAPEUTICS, INC. (US) 2017-11-16 WO disclosed